Development of Antibiotic Activity Profile Screening for the Classification and Discovery of Natural Product Antibiotics

被引:72
作者
Wong, Weng Ruh [1 ,2 ]
Oliver, Allen G. [3 ]
Linington, Roger G. [1 ]
机构
[1] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA
[2] Fed Govt Adm Ctr, Minist Sci Technol & Innovat Malaysia, Putrajaya 62662, Malaysia
[3] Univ Notre Dame, Dept Chem & Biochem, Mol Struct Facil, Notre Dame, IN 46556 USA
来源
CHEMISTRY & BIOLOGY | 2012年 / 19卷 / 11期
基金
美国国家科学基金会;
关键词
EVOLVING TRENDS; DRUG DISCOVERY; BAD BUGS; IDENTIFICATION; DEREPLICATION; RESISTANCE; EXTRACTS; BACTERIA; NMR;
D O I
10.1016/j.chembiol.2012.09.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite recognition of the looming antibiotic crisis by healthcare professionals, the number of new antibiotics reaching the clinic continues to decline sharply. This study aimed to establish an antibiotic profiling strategy using a panel of clinically relevant bacterial strains to create unique biological fingerprints for all major classes of antibiotics. Antibiotic mode of action profile (BioMAP) screening has been shown to effectively cluster antibiotics by structural class based on these fingerprints. Using this approach, we have accurately predicted the presence of known antibiotics in natural product extracts and have discovered a naphthoquinone-based antibiotic from our marine natural product library that possesses a unique carbon skeleton. We have demonstrated that bioactivity fingerprinting is a successful strategy for profiling antibiotic lead compounds and that BioMAP can be applied to the discovery of new natural product antibiotics leads.
引用
收藏
页码:1483 / 1495
页数:13
相关论文
共 38 条
  • [1] PENICILLINASE-RESISTANT PENCILLINS + CEPHALOSPORINS
    BARBER, M
    WATERWORTH, PM
    [J]. BRITISH MEDICAL JOURNAL, 1964, 2 (540) : 344 - &
  • [2] Minocycline-an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii
    Bishburg, Eliahu
    Bishburg, Kathryn
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (05) : 395 - 401
  • [3] Blunt J.W., 2009, ANTIMARIN DATABASE
  • [4] Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
    Boucher, Helen W.
    Talbot, George H.
    Bradley, John S.
    Edwards, John E., Jr.
    Gilbert, David
    Rice, Louis B.
    Scheld, Michael
    Spellberg, Brad
    Bartlett, John
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) : 1 - 12
  • [5] Chan P.F., 2004, DRUG DISCOV TODAY TH, V1, P519, DOI DOI 10.1016/J.DDSTR.2004.11.003
  • [6] Fumaquinone, a new prenylated naphthoquinone from Streptomyces fumanus
    Charan, RD
    Schlingmann, G
    Bernan, VS
    Feng, XD
    Carter, GT
    [J]. JOURNAL OF ANTIBIOTICS, 2005, 58 (04) : 271 - 274
  • [7] Antibacterial Activity of Novel Naphthoquiones Derivatives
    Chung, Yongseog
    Quan, Ren shu
    Chang, Hyeon Mo
    Kwon, Soo Han
    Kim, Soon-Ja
    Im, Young-Sam
    Shin, Kyeong Seob
    Park, Kyung-Do
    Lee, Hak-Kyo
    Choi, Joong-Kook
    [J]. GENES & GENOMICS, 2009, 31 (06) : 429 - 434
  • [8] New antibiotics from bacterial natural products
    Clardy, Jon
    Fischbach, Michael A.
    Walsh, Christopher T.
    [J]. NATURE BIOTECHNOLOGY, 2006, 24 (12) : 1541 - 1550
  • [9] Open source clustering software
    de Hoon, MJL
    Imoto, S
    Nolan, J
    Miyano, S
    [J]. BIOINFORMATICS, 2004, 20 (09) : 1453 - 1454
  • [10] DNA gyrase, topoisomerase IV, and the 4-quinolones
    Drlica, K
    Zhao, XL
    [J]. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) : 377 - +